Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HNF4A | P41235 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | PTPN5 | P54829 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15727373 | 0.93 | HNF4A (0.39) | MEN1POLBGAAKMT2AHNF4A | |
| SCHEMBL15727369 | 0.84 | MEN1 (0.43) | MEN1POLBGAAKMT2ASLC6A3 | |
| SCHEMBL15727354 | 0.82 | MEN1 (0.48) | MEN1POLBGAAKMT2ASLC6A3 | |
| SCHEMBL19419198 | 0.82 | MEN1 (0.41) | MEN1POLBGAAKMT2ASLC6A3 | |
| SCHEMBL9467530 | 0.77 | MEN1 (0.47) | MEN1POLBGAAKMT2ASLC6A3 | |
| SCHEMBL15727363 | 0.77 | MEN1 (0.40) | MEN1POLBGAAKMT2ASLC6A3 | |
| SCHEMBL26157714 | 0.75 | FABP3 (0.36) | MEN1POLBGAAKMT2ASLC6A3 | |
| SCHEMBL31634569 | 0.75 | HTR2C (0.38) | MEN1POLBGAAKMT2ASLC6A3 | |
| SCHEMBL27392603 | 0.75 | HTR2C (0.38) | MEN1POLBGAAKMT2ASLC6A3 | |
| SCHEMBL15727361 | 0.74 | MEN1 (0.39) | MEN1POLBGAAKMT2ASLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170282169-A1 | ALUMINUM CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-10-05 | — | — | US | disclosed |
| US-20170282169-A1 | ALUMINUM CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-10-05 | — | — | US | disclosed |
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| US-20150315110-A1 | ALUMINUM CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-11-05 | — | — | US | disclosed |
| US-20150315110-A1 | ALUMINUM CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-11-05 | — | — | US | disclosed |
| EP-2921229-A1 | ALUMINUM CATALYST | Takasago International Corporation (JP) | 2015-09-23 | — | — | EP | disclosed |
| EP-2921228-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | Takasago International Corporation (JP) | 2015-09-23 | — | — | EP | disclosed |
| WO-2014077323-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | 高砂香料工業株式会社 (JP) | 2014-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | ACSL3, ACSL6, ALOX5 | MEN1 481/4885POLB 1538/4885GAA 1135/4885 |
| US-20170282169-A1 | ALUMINUM CATALYST | ACSL6, ACSL3, HACL2 | MEN1 1699/4885POLB 1932/4885GAA 1271/4885 |
| US-20150315110-A1 | ALUMINUM CATALYST | ACSL6, ACSL3, HACL2 | MEN1 1699/4885POLB 1932/4885GAA 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.